Qtick
Sign in

McKesson Corporation (MCK) Competitors & Peers

The 5 companies closest to McKesson Corporation on the factors that matter — each comparable links to its own dossier. Numbers are code-computed, never estimated.

How we identify peers ↗

TickerRelationshipPriceComparables
CAHCompetitor$237.18P/E 36.1RSI 59Cap 55.5 B
CORCompetitor$325.00P/E 23.8RSI 65Cap 62.0 B
HSICPeer$88.08P/E 25.7RSI 60Cap 10.0 B
EBOSFPeer$23.75P/E 34.9RSI 100Cap 4.9 B
EBOSYPeer$26.00P/E 17.7RSI 17Cap 2.7 B

How these relationships were derived

Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.

Confirmed relationships (cited)

Sourced from a public filing or disclosure — each links to its origin.

  • BDXSupplier

    McKesson is a primary distributor of BD's medical-surgical devices, consumables, and laboratory supplies to hospitals and clinics across North America.

    Confirmed — SEC filing / public disclosuresec.gov
  • LLYSupplier

    McKesson is Eli Lilly's largest wholesale distributor, representing approximately 42% of consolidated gross revenues in FY2025.

    Confirmed — SEC filing / public disclosuresec.gov
  • BMYSupplier

    McKesson is Bristol-Myers Squibb's largest wholesale distributor, accounting for approximately 42% of gross revenues in FY2025.

    Confirmed — SEC filing / public disclosuresec.gov
  • DXCMSupplier

    McKesson is a primary wholesaler and distributor for DexCom's CGM systems in the United States, representing more than 10% of DexCom's consolidated revenue.

    Confirmed — SEC filing / public disclosureinvestors.dexcom.com
  • ORGOCustomer

    McKesson acts as a key distributor for Organogenesis, representing approximately 42% of gross revenues in FY2025.

    Confirmed — SEC filing / public disclosuresec.gov
  • ABBVSupplier

    McKesson is one of AbbVie's three primary U.S. wholesalers that collectively distribute substantially all U.S. pharmaceutical sales (no individual wholesaler exceeds 39% of U.S. gross revenues).

    Confirmed — SEC filing / public disclosuresec.gov
  • AMGNSupplier

    McKesson is one of Amgen's primary pharmaceutical wholesale distributors, individually accounting for over 10% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • JNJSupplier

    McKesson is JNJ's largest wholesale distributor, representing approximately 21.8% of consolidated gross revenues.

    Confirmed — SEC filing / public disclosuresec.gov
  • GILDSupplier

    McKesson is one of Gilead's three primary wholesale distributors, accounting for approximately 20-21% of Gilead's revenues.

    Confirmed — SEC filing / public disclosuresec.gov
  • AMPHSupplier

    Own 10-K customer-concentration disclosure: McKesson = 25% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • RIGLSupplier

    Own 10-K customer-concentration disclosure: MckessonSpecialtyCareDistributionCorporation = 45% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • CHRSSupplier

    Own 10-K customer-concentration disclosure: McKesson = 42% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • AKBASupplier

    Own 10-K customer-concentration disclosure: McKessonCorporation = 12% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • ARDXSupplier

    Own 10-K customer-concentration disclosure: McKessonCorporation = 14% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • VTRSSupplier

    Own 10-K customer-concentration disclosure: MckessonCorporation = 10% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • CVSSupplier

    McKesson is CVS Health's primary pharmaceutical distributor, supplying mail-order, specialty, and retail pharmacies. CVS represents 24% of McKesson's consolidated revenues.

    Confirmed — SEC filing / public disclosuresec.gov
  • APYXSupplier

    Own 10-Q customer-concentration disclosure: McKesson = 16% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • EYPTSupplier

    Own 10-K customer-concentration disclosure: McKessonSpecialtyCareDistributionLLC = 40% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • SUPNSupplier

    Own 10-Q customer-concentration disclosure: McKesson = 20% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • CELG-RISupplier

    Own 10-K customer-concentration disclosure: MckessonCorporation = 34% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • MGNXSupplier

    Own 10-K customer-concentration disclosure: McKessonPlasmaBiologicsAndMcKessonSpecialtyCareDistributionLLC = 12% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • EXELSupplier

    Own 10-Q customer-concentration disclosure: AffiliatesofMcKessonCorporation = 18% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • MRKSupplier

    McKesson is one of Merck's primary wholesale distributors for pharmaceutical products in the US.

    Confirmed — SEC filing / public disclosuresec.gov
  • PFESupplier

    McKesson is one of Pfizer's primary pharmaceutical wholesale distributors in the US, distributing the majority of Pfizer's branded and biosimilar products.

    Confirmed — SEC filing / public disclosuresec.gov

Model-inferred relationships (unverified)

Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.

  • HCAPartner

    McKesson and HCA Healthcare formed a strategic joint venture combining McKesson's US Oncology Research (USOR) and HCA's Sarah Cannon Research Institute (SCRI) to expand clinical trials and oncology research. McKesson holds a 51% controlling interest.

    Model-inferred, unverified — treat as a lead, not evidence
  • CORCompetitor

    Top 3 US drug distributors.

    Model-inferred, unverified — treat as a lead, not evidence
  • CAHCompetitor

    Top 3 US drug distributors.

    Model-inferred, unverified — treat as a lead, not evidence
  • PENSupplier

    McKesson acts as a wholesale distributor of Penumbra's thrombectomy and neurovascular devices to hospital systems.

    Model-inferred, unverified — treat as a lead, not evidence
  • NVOSupplier

    McKesson is Novo Nordisk's largest US wholesale distributor, representing approximately 23% of total global net sales in 2024.

    Model-inferred, unverified — treat as a lead, not evidence
  • ABTSupplier

    McKesson is a primary healthcare distributor of Abbott's diagnostics, medical devices, and nutritional products to healthcare providers.

    Model-inferred, unverified — treat as a lead, not evidence
  • MDTSupplier

    McKesson is a major wholesale distributor of Medtronic's clinical and surgical devices to hospitals.

    Model-inferred, unverified — treat as a lead, not evidence
  • EWSupplier

    McKesson is a major wholesale distributor of Edwards' structural heart devices and surgical valve components.

    Model-inferred, unverified — treat as a lead, not evidence
  • BSXSupplier

    McKesson serves as a major wholesale distributor of Boston Scientific's medical devices to hospitals and clinics.

    Model-inferred, unverified — treat as a lead, not evidence
  • SYKSupplier

    McKesson is a primary wholesale distributor of Stryker's medical devices and surgical instruments to hospitals and healthcare systems.

    Model-inferred, unverified — treat as a lead, not evidence
  • ZBHSupplier

    McKesson distributes Zimmer Biomet's medical equipment, accessories, and orthopaedic products to surgical centers and hospitals across North America.

    Model-inferred, unverified — treat as a lead, not evidence
  • SNNSupplier

    McKesson is a key distributor of Smith & Nephew's wound care, sports medicine, and surgical devices to hospitals, ambulatory surgery centers, and specialty clinics.

    Model-inferred, unverified — treat as a lead, not evidence
  • IARTSupplier

    McKesson Medical-Surgical serves as a major distributor for Integra's specialized surgical instruments and wound care product lines.

    Model-inferred, unverified — treat as a lead, not evidence
  • ALMCustomer

    McKesson distributes Alimera's ILUVIEN implants to US clinics.

    Model-inferred, unverified — treat as a lead, not evidence
  • ORGOSupplier

    McKesson acts as a major medical-surgical distributor helping fulfill ORGO's product distribution.

    Model-inferred, unverified — treat as a lead, not evidence
  • JNJSupplier

    McKesson distributes J&J pharmaceuticals.

    Model-inferred, unverified — treat as a lead, not evidence
  • MRKSupplier

    McKesson is Merck distributor.

    Model-inferred, unverified — treat as a lead, not evidence
  • PFESupplier

    McKesson is among Pfizer's largest US pharma distributors.

    Model-inferred, unverified — treat as a lead, not evidence
  • REGNSupplier

    McKesson is one of Regeneron's primary pharmaceutical wholesale distributors in the US, distributing Eylea, Dupixent, and other products.

    Model-inferred, unverified — treat as a lead, not evidence
  • UNHPartner

    McKesson supplies pharmaceuticals to Optum Rx, UNH's PBM subsidiary that manages prescription benefits for UNH's 49.8M members.

    Model-inferred, unverified — treat as a lead, not evidence
  • OGNCustomer

    McKesson is a key wholesale distributor routing Organon products to retail pharmacies and hospitals.

    Model-inferred, unverified — treat as a lead, not evidence
  • VRTXSupplier

    McKesson is one of Vertex's primary wholesale distributors for its cystic fibrosis medicines (Trikafta/Kaftrio) in the US.

    Model-inferred, unverified — treat as a lead, not evidence
  • RADSupplier

    McKesson distributes to Rite Aid (post-bankruptcy emerge).

    Model-inferred, unverified — treat as a lead, not evidence